# A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone

> **NCT04295161** · PHASE1 · COMPLETED · sponsor: **Zentiva, k.s.** · enrollment: 33 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Abiraterone Acetate

## Key facts

- **NCT ID:** NCT04295161
- **Lead sponsor:** Zentiva, k.s.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-25
- **Primary completion:** 2019-11-08
- **Final completion:** 2019-11-08
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04295161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04295161, "A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04295161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*